Reasons to Investigate the Soluble Receptor for Advanced Glycation End-Product (sRAGE) Pathway in Aortic Disease

Author： Sarkar Abdullah Prasad Kailash Ziganshin Bulat A. Elefteriades John A.

Publisher： Science International Corporation

ISSN： 2325-4637

Source： AORTA, Vol.1, Iss.3, 2013-08, pp. : 210-217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Receptor of advanced glycation end product (RAGE) expression in the minor salivary glands of patients with Sjo˝gren's syndrome: a preliminary study

By Katz J Stavropoulos F Bhattacharyya I Stewart C Perez FM Caudle RM

Scandinavian Journal of Rheumatology, Vol. 33, Iss. 3, 2004-05 ,pp. : 174-178

Informa Healthcare

Access to resources Recommend Favorite

Association of Soluble Receptor for Advanced Glycation End Products Levels with Hypertensive Albuminuria

Current Vascular Pharmacology, Vol. 13, Iss. 2, 2015-01 ,pp. : 259-264

Bentham Science Publishers

Access to resources Recommend Favorite

Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes

By Tan K. Shiu S. Chow W. Leng L. Bucala R. Betteridge D.

Diabetologia, Vol. 49, Iss. 11, 2006-11 ,pp. : 2756-2762

Springer Publishing Company

Access to resources Recommend Favorite

Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products

By Valencia J. Mone M. Koehne C. Rediske J. Hughes T.

Diabetologia, Vol. 47, Iss. 5, 2004-05 ,pp. : 844-852

Springer Publishing Company

Access to resources Recommend Favorite

Pentosidine, an Advanced Glycation Endproduct, and Arthritis

Current Rheumatology Reviews, Vol. 2, Iss. 4, 2006-11 ,pp. : 319-324

Bentham Science Publishers

Access to resources Recommend Favorite